The Predictive Value of Fibrotest vs. APRI for the Diagnosis of Fibrosis in Chronic Hepatitis C [1] (multiple letters)

Hepatology

Volumn 39, Issue 3, 2004, Pages 862-863

  Le Calvez, Sophie ^a   Thabut, Dominique ^a   Messous, Djamila ^a   Munteanu, Mona ^a   Ratziu, Vlad ^a   Imbert Bismut, Francoise ^a   Poynard, Thierry ^a   Lok, Anna S ^b   Wai, Chun Tao ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE PLATELET RATIO INDEX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FIBROTEST; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; LETTER; LIVER FIBROSIS; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; PREDICTION; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; SCORING SYSTEM; THROMBOCYTE COUNT; VALIDATION PROCESS;

ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER CIRRHOSIS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS;

EID: 1542724800     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20099     Document Type: Letter

References (0)